GPX1 and cancer: Some selenoproteins have been reported to paradoxically exert adverse consequences in certain contexts, including increased insulin sensitivity in GPx1 KO mice and increased cancer resistance in TrxR1-deficienct hepatocarcinoma and lung carcinoma cells.